News

Explore the Latest Advancements and Updates.

CME Courses – Identifying Patients in the Sepsis Gray Zone

May 15, 2025

Sepsis Probability, Antibiotic Stewardship, and Precision Medicine Using SeptiCyte® RAPID

May 1, 2025

Immunexpress CEO Rollie Carlson was a panelist at The State of Precision Medicine 2025 from @Inside_PM.

March 21, 2025

Immunexpress to Present New Data at the Society of Critical Care Medicine (SCCM) 2025 Critical Care Congress

February 24, 2025

Interview with Dr. Rollie Carlson on NPR’s Bio Tech Nation

November 13, 2024

Journal of Clinical Medicine Publication Demonstrates Clinical Utility of SeptiCyte® RAPID in Critically Ill Heterogeneous Patient Populations

October 16, 2024

Clarivate Webinar: New frontiers in diagnostics: opportunities and challenges post-pandemic

May 31, 2024

Independent Studies Presented at ESCMID Global Demonstrate the Clinical Utility of SeptiCyte® RAPID in Patients Suspected of Sepsis, Including in Polytrauma Patients

April 17, 2024

Accurate Identification of Sepsis using SeptiCyte® RAPID and Comparison with other Biomarkers Presented at Society of Critical Care Medicine Critical Care Congress 2024

January 22, 2024

SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

January 16, 2024

“Immunexpress Nabs 510(k) Clearance for EDTA Blood-Compatible Cartridges”

January 4, 2024

Immunexpress Announces U.S. FDA Clearance of EDTA Blood Compatible Cartridges for SeptiCyte RAPID®

January 4, 2024

« Previous
1
2
3
4
…
14
Next »

If you are a member of the media, please contact:

David Schull
Russo Partners, LLC
david.schull@russopartnersllc.com

Maddie Stabinski
Russo Partners, LLC
madeline.stabinski@russopartnersllc.com